Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience. (Q46075053)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Vijaya Sarathi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Dipti L Jain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Roshan Colah

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Saumil Desai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Amruta Gokhale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Amol Bhandarwar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Harshwardhan L Jain

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Kanjaksha Ghosh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

5 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

929-933

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

Sickle cell disease in India

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Clinical profile of sickle cell disease in Orissa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Effective control of sickle cell disease with hydroxyurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Sickle cell anemia: targeting the role of fetal hemoglobin in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Fetal hemoglobin response to hydroxyurea in Yemeni sickle cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

Clinical response and adverse events in young patients with sickle cell disease treated with hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

How I use hydroxyurea to treat young patients with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-013-0264-0

10.1007/S13312-013-0264-0

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798623%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference